troglitazone has been researched along with cortisone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Asai, M; Hashimoto, K; Iwasaki, Y; Kambayashi, M; Nishiyama, M; Taguchi, T; Takayasu, S; Tsugita, M; Yoshida, M | 1 |
2 other study(ies) available for troglitazone and cortisone
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Anticholesteremic Agents; Base Sequence; Cell Line; Chromans; Clofibrate; Cortisone; Cushing Syndrome; Dexamethasone; Gene Expression Regulation, Enzymologic; Glucocorticoids; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Interleukin-1beta; Liver; Metabolic Syndrome; Metformin; Molecular Sequence Data; Receptors, Glucocorticoid; Thiazolidinediones; Transcription Factor AP-1; Troglitazone; Tumor Necrosis Factor-alpha | 2008 |